These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34212231)

  • 1. COVID-19-associated liver injury (COVALI): role of hepatologists.
    Sumida Y; Yoneda M
    J Gastroenterol; 2021 Aug; 56(8):786-787. PubMed ID: 34212231
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "COVID-19-associated liver injury (COVALI): role of hepatologists".
    Li D; Ding X; Tian D; Xia L
    J Gastroenterol; 2021 Aug; 56(8):788-789. PubMed ID: 34251568
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes.
    Cooper KM; Colletta A; Asirwatham AM; Moore Simas TA; Devuni D
    World J Gastroenterol; 2022 Nov; 28(42):6017-6033. PubMed ID: 36405386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroenterologists, Hepatologists, COVID-19 and the Use of Acetaminophen.
    Rodríguez-Morales AJ; Cardona-Ospina JA; Murillo-Muñoz MM
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2142-2143. PubMed ID: 32387226
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
    Wang H; Qiu P; Liu J; Wang F; Zhao Q
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):653-661. PubMed ID: 32418852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management.
    Bloom PP; Pasricha TS; Andersson KL; Pratt DS; Hashemi N; Bhan I; Viveiros K
    Dig Dis Sci; 2021 Jun; 66(6):1852-1854. PubMed ID: 32729013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chronic Liver Failure in the COVID-19 Era.
    Premkumar M; Kajal K; Kulkarni AV; Gupta A; Divyaveer S
    J Intensive Care Med; 2021 May; 36(5):511-523. PubMed ID: 33438491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
    Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
    Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing unmet needs of gastroenterologists' training in the post-COVID-19 era.
    Marasco G; Scaldaferri F; Nardone OM
    Gastrointest Endosc; 2021 Jan; 93(1):271-272. PubMed ID: 33353623
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic insight into COVID-19-related liver injury.
    Bianco C; Baselli G; Malvestiti F; Santoro L; Pelusi S; Manunta M; Grasselli G; Bandera A; Scudeller L; Prati D; Valenti L
    Liver Int; 2021 Jan; 41(1):227-229. PubMed ID: 33098230
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver Biopsy Shines a Light on COVID-19-Related Liver Injury.
    Kleiner DE
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):881-882. PubMed ID: 33144089
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver injury in COVID-19: clinical features and treatment management.
    Yu D; Du Q; Yan S; Guo XG; He Y; Zhu G; Zhao K; Ouyang S
    Virol J; 2021 Jun; 18(1):121. PubMed ID: 34108015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic.
    Chang JPE; Wong YJ; Yang WL; Lim KBL; Tan PS; Ho GH; Yip BCH; Li JW; Chong CH; Ong DEH; Chua TS; Vu CKF; Gwee KA; Ang TL; Tan CK
    Singapore Med J; 2020 Dec; 61(12):619-623. PubMed ID: 32349198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 - more than respiratory disease: a gastroenterologist's perspective.
    Konturek PC; Harsch IA; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and the liver: What do we know after six months of the pandemic?
    Fierro NA
    Ann Hepatol; 2020; 19(6):590-591. PubMed ID: 32956871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.